glp 1 drugs origin Timeline of GLP-1 discovery and clinical development. (a) Key events in The GLP-1 Agonists and Obesity:
Description
Effect of Different Antidiabetic Medications on Atherosclerotic Cardiovascular Disease (ASCVD) Risk Score among Patients with Type-2 Diabetes Mellitus: A Multicenter Non-Interventional Observational Study
Open 7 , e2421305 (2024)
Adoption of obesity GLP-1 is increasing because of the expansion of regulatory approvals for weight management
Rinella, M
Hamano T, Enomoto S, Shirafuji N, Ikawa M, Yamamura O, Yen SH, et al
